183 related articles for article (PubMed ID: 24308679)
1. Prostate stem cell antigen and cancer risk, mechanisms and therapeutic implications.
Yang X; Guo Z; Liu Y; Si T; Yu H; Li B; Tian W
Expert Rev Anticancer Ther; 2014 Jan; 14(1):31-7. PubMed ID: 24308679
[TBL] [Abstract][Full Text] [Related]
2. Prostate stem cell antigen - novel biomarker and therapeutic target?
Bargão Santos P; Patel HR
Expert Rev Anticancer Ther; 2014 Jan; 14(1):5-7. PubMed ID: 24320701
[TBL] [Abstract][Full Text] [Related]
3. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
4. External beam radiotherapy (EBRT) suppressed prostate stem cell antigen (PSCA) mRNA expression in clinically localized prostate cancer.
Zhigang Z; Wenlu S
Prostate; 2007 May; 67(6):653-60. PubMed ID: 17342746
[TBL] [Abstract][Full Text] [Related]
5. PSCA mRNA expression in preoperatively negative prostate biopsies predicts incidental prostate cancer in patients undergoing transurethral resection of the prostate for benign prostatic hyperplasia.
Zhao Z; Ma W; Zeng G; Qi D
J Surg Oncol; 2011 Nov; 104(6):672-8. PubMed ID: 21674503
[TBL] [Abstract][Full Text] [Related]
6. Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer.
Zhigang Z; Wenlv S
Jpn J Clin Oncol; 2004 Jul; 34(7):414-9. PubMed ID: 15342669
[TBL] [Abstract][Full Text] [Related]
7. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells.
Zhao Z; Ma W; Zeng G; Qi D; Ou L; Liang Y
Urol Oncol; 2013 Apr; 31(3):343-51. PubMed ID: 21429770
[TBL] [Abstract][Full Text] [Related]
8. Growth, regeneration, and tumorigenesis of the prostate activates the PSCA promoter.
Watabe T; Lin M; Ide H; Donjacour AA; Cunha GR; Witte ON; Reiter RE
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):401-6. PubMed ID: 11752398
[TBL] [Abstract][Full Text] [Related]
9. RNA interference targeting PSCA suppresses primary tumor growth and metastasis formation of human prostate cancer xenografts in SCID mice.
Zhao Z; He J; Kang R; Zhao S; Liu L; Li F
Prostate; 2016 Feb; 76(2):184-98. PubMed ID: 26477693
[TBL] [Abstract][Full Text] [Related]
10. Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis.
Ono H; Hiraoka N; Lee YS; Woo SM; Lee WJ; Choi IJ; Saito A; Yanagihara K; Kanai Y; Ohnami S; Chiwaki F; Sasaki H; Sakamoto H; Yoshida T; Saeki N
Genes Chromosomes Cancer; 2012 Jan; 51(1):30-41. PubMed ID: 21936014
[TBL] [Abstract][Full Text] [Related]
11. Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer.
Fawzy MS; Mohamed RH; Elfayoumi AR
Med Oncol; 2015 Mar; 32(3):74. PubMed ID: 25698533
[TBL] [Abstract][Full Text] [Related]
12. Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.
Dong L; Zhang X; Ren J; Wu S; Yu T; Hou L; Fu L; Yi S; Yu C
Cancer Biother Radiopharm; 2013 Jun; 28(5):391-7. PubMed ID: 23701419
[TBL] [Abstract][Full Text] [Related]
13. [Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma].
Yagn WB; Cai F; Cheng CT; Cao G; Qin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Dec; 30(6):728-31. PubMed ID: 19180924
[TBL] [Abstract][Full Text] [Related]
14. Prostate stem cell antigen is overexpressed in prostate cancer metastases.
Lam JS; Yamashiro J; Shintaku IP; Vessella RL; Jenkins RB; Horvath S; Said JW; Reiter RE
Clin Cancer Res; 2005 Apr; 11(7):2591-6. PubMed ID: 15814638
[TBL] [Abstract][Full Text] [Related]
15. Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody-based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells.
Arndt C; Feldmann A; Töpfer K; Koristka S; Cartellieri M; Temme A; Ehninger A; Ehninger G; Bachmann M
Prostate; 2014 Sep; 74(13):1347-58. PubMed ID: 25053504
[TBL] [Abstract][Full Text] [Related]
16. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.
Reiter RE; Gu Z; Watabe T; Thomas G; Szigeti K; Davis E; Wahl M; Nisitani S; Yamashiro J; Le Beau MM; Loda M; Witte ON
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1735-40. PubMed ID: 9465086
[TBL] [Abstract][Full Text] [Related]
17. Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients.
Taeb J; Asgari M; Abolhasani M; Farajollahi MM; Madjd Z
Pathol Res Pract; 2014 Jan; 210(1):18-23. PubMed ID: 24183365
[TBL] [Abstract][Full Text] [Related]
18. Prostate stem cell antigen: a Jekyll and Hyde molecule?
Saeki N; Gu J; Yoshida T; Wu X
Clin Cancer Res; 2010 Jul; 16(14):3533-8. PubMed ID: 20501618
[TBL] [Abstract][Full Text] [Related]
19. Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer.
Dannull J; Diener PA; Prikler L; Fürstenberger G; Cerny T; Schmid U; Ackermann DK; Groettrup M
Cancer Res; 2000 Oct; 60(19):5522-8. PubMed ID: 11034097
[TBL] [Abstract][Full Text] [Related]
20. Prostate stem cell antigen is a putative target for immunotherapy in pancreatic cancer.
Wente MN; Jain A; Kono E; Berberat PO; Giese T; Reber HA; Friess H; Büchler MW; Reiter RE; Hines OJ
Pancreas; 2005 Aug; 31(2):119-25. PubMed ID: 16024997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
